Mapping a disordered portion of the Brz2001-binding site on a plant monooxygenase, DWARF4, using a quartz-crystal microbalance biosensor-based T7 phage display

Assay and Drug Development Technologies

Volumn 11, Issue 3, 2013, Pages 206-215

  Takakusagi, Yoichi ^a,b   Manita, Daisuke ^a   Kusayanagi, Tomoe ^a   Izaguirre Carbonell, Jesus ^a   Takakusagi, Kaori ^a   Kuramochi, Kouji ^a   Iwabata, Kazuki ^a   Kanai, Yoshihiro ^a   Sakaguchi, Kengo ^a   Sugawara, Fumio ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRASSINOSTEROID; SELF ASSEMBLED MONOLAYER; UNSPECIFIC MONOOXYGENASE;

AMINO ACID SEQUENCE; ARTICLE; BACTERIOPHAGE T7; BINDING SITE; BIOINFORMATICS; BIOPANNING; BIOSENSOR; PEPTIDE LIBRARY; QUARTZ CRYSTAL MICROBALANCE; SOLUBILITY;

AMINO ACID SEQUENCE; ARABIDOPSIS PROTEINS; BACTERIOPHAGE T7; BINDING SITES; BIOSENSING TECHNIQUES; CYTOCHROME P-450 ENZYME SYSTEM; DNA, VIRAL; INDICATORS AND REAGENTS; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SOFTWARE; TRIAZOLES; VIRAL PLAQUE ASSAY;

EID: 84876008991     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2012.478     Document Type: Article

References (41)

1. Crews CM: Targeting the undruggable proteome: the small molecules of my dreams. Chem Biol 2010;17:551-555.
2. Takakusagi Y, Takakusagi K, Sugawara F, Sakaguchi K: Use of phage display technology for the determination of the targets for small-molecule therapeutics. Expert Opin Drug Discov 2010;5:361-389.
3. Takakusagi Y, Takakusagi K, Sugawara F, Sakaguchi K: [Validation of small-molecule/protein interactions by the T7 phage display strategy using a quartz-crystal microbalance device]. Tanpakushitsu Kakusan Koso 2009;54:1203-1209.
4. Takakusagi Y, Kuramochi K, Takagi M, et al.: Efficient one-cycle affinity selection of binding proteins or peptides specific for a small-molecule using a T7 phage display pool. Bioorg Med Chem 2008;16:9837-9846.
5. Takakusagi Y, Kuroiwa Y, Sugawara F, Sakaguchi K: Identification of a methotrexate-binding peptide from a T7 phage display screen using a QCM device. Bioorg Med Chem 2008;16:7410-7414.
6. Takakusagi Y, Takakusagi K, Kuramochi K, Kobayashi S, Sugawara F, Sakaguchi K: Identification of C10 biotinylated camptothecin (CPT-10-B) binding peptides using T7 phage display screen on a QCM device. Bioorg Med Chem 2007;15:7590-7598.
7. Sauerbrey G: The use of quartz oscillators for weighing thin layers and for microweighing. Z Phys 1959;155:206-222.
8. Speight RE, Cooper MA: A survey of the 2010 quartz crystal microbalance literature. J Mol Recognit 2012;25:451-473.
9. Becker B, Cooper MA: A survey of the 2006-2009 quartz crystal microbalance biosensor literature. J Mol Recognit 2011;24:754-787.
10. Cooper MA, Singleton VT: A survey of the 2001 to 2005 quartz crystal microbalance biosensor literature: applications of acoustic physics to the analysis of biomolecular interactions. J Mol Recognit 2007;20:154-184.
11. Makowski L. Quantitative analysis of peptide libraries. In: Phage Nanobiotechnology. Petrenko VA, Smith GP, (eds.), pp. 33-54. RSC Publishing, Cambridge, United Kingdom, 2011.
12. Carter DM, Gagnon JN, Damlaj M, et al.: Phage display reveals multiple contact sites between FhuA, an outer membrane receptor of Escherichia coli, and TonB. J Mol Biol 2006;357:236-251.
13. Mandava S, Makowski L, Devarapalli S, Uzubell J, Rodi DJ: RELIC-a bioinformatics server for combinatorial peptide analysis and identification of protein-ligand interaction sites. Proteomics 2004;4:1439-1460.
14. Rodi DJ, Agoston GE, Manon R, Lapcevich R, Green SJ, Makowski L: Identification of small molecule binding sites within proteins using phage display technology. Comb Chem High Throughput Screen 2001;4:553-572.
15. Rodi DJ, Makowski L: Similarity between the sequences of taxol-selected peptides and the disordered loop of the anti-apoptotic protein, Bcl-2. Pac Symp Biocomput 1999:532-541.
16. Rodi DJ, Janes RW, Sanganee HJ, Holton RA, Wallace BA, Makowski L: Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein. J Mol Biol 1999;285:197-203.
17. Rezaei-Ghaleh N, Blackledge M, Zweckstetter M: Intrinsically disordered proteins: from sequence and conformational properties toward drug discovery. ChemBioChem 2012;13:930-950.
18. Metallo SJ: Intrinsically disordered proteins are potential drug targets. Curr Opin Chem Biol 2010;14:481-488.
19. Uversky VN, Dunker AK: Understanding protein non-folding. Biochim Biophys Acta 2010;1804:1231-1264.
20. Hadfield AT, Diana GD, Rossmann MG: Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16. Proc Natl Acad Sci USA 1999;96:14730-14735.
21. Curry S, Mandelkow H, Brick P, Franks N: Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 1998;5:827-835.
22. Mattos C, Rasmussen B, Ding X, Petsko GA, Ringe D: Analogous inhibitors of elastase do not always bind analogously. Nat Struct Biol 1994;1:55-58.
23. Makowski L, Soares A: Estimating the diversity of peptide populations from limited sequence data. Bioinformatics 2003;19:483-489.
24. Rodi DJ, Soares AS, Makowski L: Quantitative assessment of peptide sequence diversity in M13 combinatorial peptide phage display libraries. J Mol Biol 2002;322:1039-1052.
25. Sekimata K, Kimura T, Kaneko I, et al.: A specific brassinosteroid biosynthesis inhibitor, Brz2001: evaluation of its effects on Arabidopsis, cress, tobacco, and rice. Planta 2001;213:716-721.
26. Min YK, Asami T, Fujioka S, Murofushi N, Yamaguchi I, Yoshida S: New lead compounds for brassinosteroid biosynthesis inhibitors. Bioorg Med Chem Lett 1999;9:425-430.
27. Asami T, Mizutani M, Fujioka S, et al.: Selective interaction of triazole derivatives with DWF4, a cytochrome P450 monooxygenase of the brassinosteroid biosynthetic pathway, correlates with brassinosteroid deficiency in planta. J Biol Chem 2001;276:25687-25691.
28. Cheng CI, Chang YP, Chu YH: Biomolecular interactions and tools for their recognition: focus on the quartz crystal microbalance and its diverse surface chemistries and applications. Chem Soc Rev 2012;41:1947-1971.
29. Love JC, Estroff LA, Kriebel JK, Nuzzo RG, Whitesides GM: Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem Rev 2005;105:1103-1169.
30. Wink T, van Zuilen SJ, Bult A, van Bennkom WP: Self-assembled monolayers for biosensors. Analyst 1997;122:43R-50R.
31. Takakusagi Y, Takakusagi K, Ida N, et al.: Binding region and interaction properties of sulfoquinovosylacylglycerol (SQAG) with human vascular endothelial growth factor 165 revealed by biosensor-based assays. MedChemComm 2011;2:1188-1193.
32. Mao X, Yang L, Su XL, Li Y: A nanoparticle amplification based quartz crystal microbalance DNA sensor for detection of Escherichia coli O157:H7. Biosens Bioelectron 2006;21:1178-1185.
33. Henne WA, Doorneweerd DD, Lee J, Low PS, Savran C: Detection of folate binding protein with enhanced sensitivity using a functionalized quartz crystal microbalance sensor. Anal Chem 2006;78:4880-4884.
34. Wester MR, Yano JK, Schoch GA, et al.: The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution. J Biol Chem 2004;279:35630-35637.
35. Williams PA, Cosme J, Ward A, Angove HC, Matak Vinkovic D, Jhoti H: Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature 2003;424:464-468.
36. Bajguz A, Asami T: Suppression of Wolffia arrhiza growth by brassinazole, an inhibitor of brassinosteroid biosynthesis and its restoration by endogenous 24-epibrassinolide. Phytochemistry 2005;66:1787-1796.
37. Bajguz A, Asami T: Effects of brassinazole, an inhibitor of brassinosteroid biosynthesis, on light-and dark-grown Chlorella vulgaris. Planta 2004;218: 869-877.
38. Yoshimitsu Y, Tanaka K, Fukuda W, et al.: Transcription of DWARF4 plays a crucial role in auxin-regulated root elongation in addition to brassinosteroid homeostasis in Arabidopsis thaliana. PLoS One 2011;6:e23851.
39. Sekimata K, Ohnishi T, Mizutani M, et al.: Brz220 interacts with DWF4, a cytochrome P450 monooxygenase in brassinosteroid biosynthesis, and exerts biological activity. Biosci Biotechnol Biochem 2008;72:7-12.
40. Nagata N, Asami T, Yoshida S: Brassinazole, an inhibitor of brassinosteroid biosynthesis, inhibits development of secondary xylem in cress plants (Lepidium sativum). Plant Cell Physiol 2001;42:1006-1011.
41. Nagata N, Min YK, Nakano T, Asami T, Yoshida S: Treatment of dark-grown Arabidopsis thaliana with a brassinosteroid-biosynthesis inhibitor, brassinazole, induces some characteristics of light-grown plants. Planta 2000;211:781-790.